MK-8237 (SCH900237)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8237 (SCH900237), covering 2017-02-13 to 2017-02-13. Get the full timeline:
Most recent: Clinical Trial Update: MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) [Phase 1]